TickerFactsScreenerDevelopers

Protara Therapeutics, Inc. (TARA) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2012: $67.0K2013: $10.0K2014: $51.0K2015: $198.0K2016: $271.0K2017: $35.0K2018: $119.0K2019: $475.0K2020: $884.0K2021: $596.0K2022: $120.0K2023: $45.0K2024: $63.0K2025: $94.0K$94.0K
2012Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$94.0K+49.2%
2024$63.0K+40.0%
2023$45.0K-62.5%
2022$120.0K-79.9%
2021$596.0K-32.6%
2020$884.0K+86.1%
2019$475.0K+299.2%
2018$119.0K+240.0%
2017$35.0K-87.1%
2016$271.0K+36.9%
2015$198.0K+288.2%
2014$51.0K+410.0%
2013$10.0K-85.1%
2012$67.0K—